ArticleCancers2022

Real World Evaluation of the Prosigna/PAM50 Test in a Node-Negative Postmenopausal Swedish Population: A Multicenter Study.

Una Kjällquist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.